Suraksha Diagnostic is a leading healthcare provider in India, specializing in diagnostic services and medical testing. Known for its commitment to quality and accuracy, Suraksha offers a wide range of pathology tests and imaging services to help patients with early disease detection and effective treatment. The company aims to provide reliable, affordable, and accessible healthcare services to individuals across India. As of December, 09, 2024, the Suraksha Diagnostic share price on the NSE is ₹412. Below are the projected Suraksha Diagnostic share price target for the years 2024, 2025, 2026, 2027, 2030, 2035 And 2040.
Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360
Suraksha Diagnostic Company Overview
Founded with the goal of offering high-quality diagnostic services, Suraksha Diagnostic operates a network of well-equipped diagnostic centers and labs, serving patients across major cities in India. The company provides a broad spectrum of services, including routine blood tests, specialized diagnostic tests, imaging services like X-ray and ultrasound, as well as health checkup packages.
| Company type | Privet |
| Traded as | NSE: SURAKSHA BSE: 544293 |
| Industry | Healthcare |
| Founded | 2005; 19 years ago |
| Headquarters | Kolkata, Bengal, India |
| Area served | India |
| Key people | Ritu Mittal Somnath Chatterjee Karan Kanika Verma Kishan Kumar Kejriwal |
| Services | Pathology Radiology testing Medical consultation |
| Revenue | ₹219 crore (2024) |
| Net Profit | ₹24 crore (2024) |
| Total assets | ₹302 crore (2024) |
| Number of employees | 1,180 (2024) |
| Website | https://www.surakshanet.com/ |
Suraksha Diagnostic Share Price Target from 2025-2040 Forecast
| Year | Year High Target (₹) | Year Low Target (₹) | Year-End Target (₹) |
| 2024 | ₹460 | ₹380 | ₹430 |
| 2025 | ₹550 | ₹410 | ₹500 |
| 2026 | ₹630 | ₹480 | ₹610 |
| 2027 | ₹750 | ₹570 | ₹720 |
| 2028 | ₹830 | ₹640 | ₹800 |
| 2029 | ₹950 | ₹750 | ₹910 |
| 2030 | ₹1060 | ₹820 | ₹1010 |
| 2035 | ₹1850 | ₹950 | ₹1670 |
| 2040 | ₹2600 | ₹1400 | ₹2150 |
Technical Analysis for Suraksha Diagnostic
Suraksha Diagnostic Share Price Target 2025
| Year | 1st Target | 2nd Target |
| 2025 | ₹500 | ₹550 |
Suraksha Diagnostic is positioned for strong growth, driven by its expanding network of diagnostic centers and increasing demand for healthcare services in India. With a commitment to providing high-quality diagnostic solutions and an efficient business model, Suraksha is set to benefit from the rising healthcare awareness and preference for diagnostic services. For 2025, our analysis projects a first target share price of ₹500, with a second target reaching ₹550 by the year-end.
Read More: Max Healthcare Share Price Target 2025, 2030,2035, 2040
Suraksha Diagnostic Share Price Target 2026
| Year | 1st Target | 2nd Target |
| 2026 | ₹590 | ₹630 |
Suraksha Diagnostic is likely to continue its growth trajectory in 2026, leveraging its extensive customer base and expanding geographical presence. The company’s consistent investments in technology and service excellence are expected to contribute to higher profitability. The first target share price for 2026 is estimated at ₹590, with a second target of ₹630, reflecting ongoing business expansion and strong market demand.
Suraksha Diagnostic Share Price Target 2027
| Year | 1st Target | 2nd Target |
| 2027 | ₹700 | ₹750 |
By 2027, Suraksha Diagnostic’s continued market dominance and expansion into new regions could further enhance its valuation. With a focus on improving operational efficiency and scaling up its services, the company is projected to reach a first target share price of ₹700, with a second target of ₹750, signaling healthy growth and investor optimism.
Suraksha Diagnostic Share Price Target 2028
| Year | 1st Target | 2nd Target |
| 2028 | ₹790 | ₹830 |
Suraksha Diagnostic is expected to see continued upward momentum in 2028, supported by a growing customer base and potential partnerships with healthcare providers. The company’s focus on increasing accessibility and offering advanced diagnostic services should boost its market share. The first target share price for 2028 is forecasted to reach ₹790, with a second target of ₹830, reflecting its strong position in the healthcare industry.
Suraksha Diagnostic Share Price Target 2029
| Year | 1st Target | 2nd Target |
| 2029 | ₹900 | ₹950 |
In 2029, Suraksha Diagnostic’s expansion into new verticals and ongoing innovation in diagnostic technology could lead to further stock price appreciation. The company’s ability to adapt to the evolving healthcare landscape is expected to attract more investors. The first target share price is anticipated to be ₹900, with a second target of ₹950, marking a continued positive growth trend.
Suraksha Diagnostic Share Price Target 2030
| Year | 1st Target | 2nd Target |
| 2030 | ₹1010 | ₹1060 |
Looking to 2030, Suraksha Diagnostic is set to become a significant player in the healthcare sector, benefiting from the increasing adoption of diagnostics as an essential part of healthcare. By this time, the company is likely to see significant increases in both revenue and profitability, with a first target share price of ₹1010, and a second target of ₹1060, showcasing long-term growth potential.
Suraksha Diagnostic Share Price Target 2035
| Year | 1st Target | 2nd Target |
| 2035 | ₹1500 | ₹1850 |
By 2035, Suraksha Diagnostic is expected to be firmly established as a leading diagnostic services provider, with a highly diversified portfolio and a loyal customer base. As a result, the first target share price is projected at ₹1500, with a second target of ₹1850, reflecting sustained growth and long-term value creation for investors.
Read More:- Fortis Healthcare Share Price Target 2025, 2030, 2035, 2040
Suraksha Diagnostic Share Price Target 2040
| Year | 1st Target | 2nd Target |
| 2040 | ₹2350 | ₹2600 |
Over the long term, Suraksha Diagnostic’s continued focus on service expansion, technological advancements, and partnerships within the healthcare ecosystem is expected to propel its valuation. For 2040, the first target share price is projected at ₹2350, with a second target of ₹2600, signifying robust growth potential and a dominant market position.
Suraksha Diagnostic Fundamentals
| Parameter | Value |
| Market Cap | ₹2,177 Cr |
| P/E Ratio (TTM) | 92.06 |
| P/B Ratio | 12.12 |
| Industry P/E | 74.40 |
| Debt to Equity | 0.47 |
| ROE | 0.00% |
| EPS (TTM) | 4.54 |
| Dividend Yield | 0.00% |
| 52 Week High | ₹411 |
| 52 Week Low | ₹449 |
| Book Value | 34.48 |
| Face Value | 2 |
Suraksha Diagnostic Financial Results
| All in ₹Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
| Sales | 158 | 140 | 223 | 190 | 219 |
| Expenses | 123 | 115 | 175 | 142 | 144 |
| Operating Profit | 34 | 25 | 48 | 48 | 74 |
| OPM % | 22% | 18% | 22% | 25% | 34% |
| Other Income | 2 | -1 | 2 | 1 | 1 |
| Interest | 2 | 2 | 2 | 10 | 10 |
| Depreciation | 13 | 16 | 15 | 32 | 33 |
| Profit before tax | 21 | 6 | 33 | 8 | 33 |
| Tax % | 28% | -1% | 28% | 9% | 25% |
| Net Profit | 15 | 6 | 24 | 7 | 24 |
| EPS in Rs | 220.43 | 93.77 | 344.20 | 104.20 | 353.33 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
Suraksha Diagnostic Balance Sheet
| All in ₹Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
| Equity Capital | 7 | 7 | 7 | 7 | 7 |
| Reserves | 111 | 118 | 141 | 148 | 172 |
| Borrowings | 13 | 18 | 21 | 99 | 92 |
| Other Liabilities | 42 | 28 | 32 | 29 | 30 |
| Total Liabilities | 173 | 171 | 201 | 282 | 302 |
| Fixed Assets | 128 | 119 | 119 | 195 | 211 |
| CWIP | 0 | 0 | 1 | 2 | 1 |
| Investments | 5 | 6 | 0 | 0 | 1 |
| Other Assets | 39 | 46 | 80 | 84 | 88 |
| Total Assets | 173 | 171 | 201 | 282 | 302 |
Suraksha Diagnostic Shareholding Pattern
| Dec 2024 | |
| Promoters | 48.78% |
| FIIs | 15.65% |
| DIIs | 16.68% |
| Public | 18.88% |
| No. of Shareholders | 1,33,085 |
Suraksha Diagnostic Peers comparison
| Name | P/E | Mar Cap ₹Cr. | Div Yld% | NP Qtr ₹Cr. | ROCE% |
| Max Healthcare | 101.93 | 107989.21 | 0.14 | 281.81 | 16.00 |
| Apollo Hospitals | 87.28 | 103237.39 | 0.22 | 395.70 | 15.11 |
| Fortis Health. | 78.51 | 54024.79 | 0.14 | 193.08 | 10.34 |
| Global Health | 64.86 | 31640.94 | 0.00 | 130.81 | 19.32 |
| Poly Medicure | 98.62 | 29082.56 | 0.11 | 87.45 | 23.62 |
| Narayana Hrudaya | 34.77 | 27085.96 | 0.30 | 198.80 | 26.54 |
| Dr Lal Pathlabs | 65.13 | 26144.44 | 0.79 | 130.80 | 25.17 |
FAQs
Q.1. What is the share price target for Suraksha Diagnostic in 2025?
Ans: The price is expected to be around ₹500 for the first target and ₹550 for the second target. This reflects the company’s steady growth.
Q.2. What are the projected share price targets for Suraksha Diagnostic in 2026?
Ans: By 2026, the share price might rise to ₹590 for the first target and ₹630 for the second target, showing continued expansion in its diagnostic services.
Q.3. What is the share price target for Suraksha Diagnostic in 2027?
Ans: In 2027, the price could increase further to ₹700 for the first target and ₹750 for the second target, indicating strong business performance.
Q.4. What are the share price targets for Suraksha Diagnostic in 2028?
Ans: For 2028, the price is estimated to reach ₹790 for the first target and ₹830 for the second target, as the company attracts more customers.
Q.5. What is the forecast for Suraksha Diagnostic share price in 2029?
Ans: By 2029, the share price might grow to ₹900 for the first target and ₹950 for the second target, reflecting improved operations and services.
Q.6. What are the share price targets for Suraksha Diagnostic in 2030?
Ans: In 2030, the price could rise to ₹1010 for the first target and ₹1060 for the second target, marking a significant milestone in its growth.
Q.7. What are the long-term share price targets for Suraksha Diagnostic in 2035?
Ans: By 2035, the share price is expected to climb to ₹1500 for the first target and ₹1850 for the second target, as Suraksha Diagnostic becomes a trusted name in healthcare.
Q.8. What is the share price target for Suraksha Diagnostic in 2040?
Ans: In the long term, by 2040, the price might reach ₹2350 for the first target and ₹2600 for the second target, showing substantial progress in its industry leadership.
Q.9. What is the NSE & BSE code for Suraksha Diagnostic?
Ans: Suraksha Diagnostic Ltd., listed on both the BSE and NSE, has the following stock details: NSE Symbol: SURAKSHA, BSE Code: 544293
TradeWatch360 is a premier platform dedicated to providing real-time insights, trends, and updates in the stock market. It is designed to support both new and seasoned investors by delivering timely and actionable information across a range of asset classes, including stocks, futures, commodities, and global markets.